Table 3 Clustering of metabolic syndrome components among participants
Type/No. of MS components | Male (No.) | % (95% CI) | Female (No.) | % (95% CI) | Total (No.) | % (95% CI) |
|---|---|---|---|---|---|---|
MS component | ||||||
 High TG | 44 | 24.3 (18.6–31.2) | 95 | 38.2 (32.3–44.4) | 139 | 32.3 (28.1–36.9) |
 High DBP | 65 | 35.9 (29.2–43.2) | 91 | 36.5 (30.8–42.8) | 156 | 36.3 (31.9–41.0) |
 High SBP | 95 | 52.5 (45.1–59.7) | 119 | 47.8 (41.6–54.0) | 214 | 49.8 (45.0–54.5) |
 Elevated WC | 75 | 41.1 (34.4–48.8) | 187 | 75.1 (69.3–80.1) | 262 | 60.9 (56.2–65.4) |
 Elevated FBG | 138 | 76.2 (69.4–81.9) | 199 | 79.9 (74.4–84.5) | 337 | 78.4 (74.2–82.0) |
 Low HDL | 119 | 65.4 (58.5–72.4) | 183 | 73.5 (67.6–78.6) | 302 | 70.2 (65.7–74.4) |
 Obese/overweight | 92 | 50.8 (43.5–58.1) | 137 | 55.0 (48.8–61.1) | 229 | 53.3 (48.5–57.9) |
No. of components present | ||||||
 1 | 5 | 2.8 (1.1–6.5) | 11 | 4.4 (2.4–7.8) | 16 | 3.7 (2.2–6.0) |
 2 | 74 | 40.9 (33.9–48.3) | 50 | 20.1 (15.5–25.6) | 124 | 28.8 (24.7–33.3) |
 3 | 53 | 29.3 (23.1–36.4) | 63 | 25.3 (20.3–31.1) | 116 | 26.9 (23.0–31.4) |
 4 | 38 | 21.0 (15.6–27.6) | 86 | 34.5 (28.9–40.7) | 124 | 28.8 (24.7–33.3) |
 5 | 11 | 6.1 (3.4–10.7) | 39 | 15.7 (11.6–20.8) | 50 | 11.6 (8.9–15.0) |
  ≥ 3 (MS) | 105 | 42.0 (35.0–49.4) | 190 | 76.3 (70.6–81.2) | 295 | 68.6 (64–0-0.72.8) |